Is adjuvant chemotherapy necessary for patients with microinvasive breast cancer after surgery?
<b>Objective: </b>Survival and treatment of patients with microinvasive breast cancer (MIBC) remain controversial. In this paper, we evaluated whether adjuvant chemotherapy is necessary for patients with MIBC to identify risk factors influencing its prognosis and decide the indication fo...
Main Authors: | Hai-Fei Niu, Li-Juan Wei, Jin-Pu Yu, Zhen Lian, Jing Zhao, Zi-Zheng Wu, Jun-Tian Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2016-03-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/918 |
Similar Items
-
Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
by: Francesca Magnoni, et al.
Published: (2023-05-01) -
Mıcroınvasıve Breast Carcınoma: A Clınıcopathologıcal Evaluatıon Of Twenty-Seven Cases
by: Betül Bolat Küçükzeybek, et al.
Published: (2018-07-01) -
Prognostic Factors and a Nomogram Predicting Survival in Patients with Breast Ductal Carcinoma in situ with Microinvasion: A Population-Based Study
by: Zheng YZ, et al.
Published: (2021-11-01) -
Survival and Time to Initiation of Adjuvant Chemotherapy Among Breast Cancer Patients in Uruguay
by: Castillo C, et al.
Published: (2021-12-01) -
Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma
by: Hua Xing, et al.
Published: (2011-11-01)